Metraipolis › archive › dc_7ed403e71edd

Prognostic benefit of immunosuppressive agents in primary Sjögren's syndrome patients with hypergammaglobulinemia — Europe PMC PMID:41909646

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41909646
DOI: 10.3389/fimmu.2026.1772604
License (as archived): solo-consultazione
Archived: 2026-11-04T12:31:53.876Z
SHA-256 of the archived text: 28f4a54d967d3b30c30dbbcfc6eb1cb89468cb1a389f642369d56f9a6428279e
Stable URL of this page: https://metraipolis.com/documento/dc_7ed403e71edd

How to cite

Prognostic benefit of immunosuppressive agents in primary Sjögren's syndrome patients with hypergammaglobulinemia — Europe PMC PMID:41909646 — Europe PMC (en), https://europepmc.org/article/MED/41909646 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ed403e71edd (Metraipolis archive dc_7ed403e71edd, sha256 28f4a54d967d3b30c30dbbcfc6eb1cb89468cb1a389f642369d56f9a6428279e)

BibTeX

@misc{dc7ed403e71edd,
  title = {Prognostic benefit of immunosuppressive agents in primary Sjögren's syndrome patients with hypergammaglobulinemia — Europe PMC PMID:41909646},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41909646},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ed403e71edd; sha256 28f4a54d967d3b30c30dbbcfc6eb1cb89468cb1a389f642369d56f9a6428279e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41909646. Agents can read the archived copy with the MCP tool read_document.